SCHEMBL13680540

SCHEMBL13680540

COC(=O)c1ccc(-c2nc(C)cs2)cn1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DYRK1A Q13627 1/20 0.52
MAPK1 P28482 2/20 0.49
CYP2E1 P05181 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2A6 P11509 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2B6 P20813 1/20 0.46
MAOA P21397 1/20 0.42
ACHE P22303 1/20 0.42
NPC1 O15118 1/20 0.42
POLB P06746 1/20 0.42
RAB9A P51151 1/20 0.42
ALDH1A1 P00352 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
AOC3 Q16853 2/20 0.40
KDM4E B2RXH2 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
HPGDS O60760 1/20 0.40
PPARA Q07869 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13680491 0.84 ALDH1A1 (0.55) CYP2E1CYP3A4CYP2A6CYP2C9CYP2B6
SCHEMBL13680524 0.80 MAPT (0.58) NPC1POLBRAB9AALDH1A1MEN1
SCHEMBL21547893 0.77 MAOA (0.56) MAOAACHENPC1POLBRAB9A
SCHEMBL31341058 0.77 HPGDS (0.46) DYRK1AMAPK1MAOAACHEHPGDS
SCHEMBL18003514 0.77 MAOA (0.50) DYRK1AMAOAACHENPC1POLB
SCHEMBL29910977 0.76 MAOA (0.61) MAOAACHENPC1POLBRAB9A
SCHEMBL13680554 0.75 GRM5 (0.53) DYRK1AMAPK1CYP2A6MEN1KMT2A
SCHEMBL6840352 0.75 CYP3A4 (0.64) MAPK1CYP2E1CYP3A4CYP2A6CYP2C9
SCHEMBL13680539 0.75 CYP19A1 (0.61) CYP2E1CYP3A4CYP2A6CYP2C9CYP2B6
SCHEMBL13680748 0.73 CYP2E1 (0.40) CYP2E1CYP3A4CYP2A6CYP2C9CYP2B6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7582658-B2 Bicyclic compound ASAHI KASEI PHARMA CORPORATION (JP) 2009-09-01 US disclosed